Skip to main content
. 2007 Jun;148(3):564–572. doi: 10.1111/j.1365-2249.2007.03372.x

Table 1.

Phenotype of immature dendritic cells (DCs) and lipopolysaccharide (LPS)-activated DCs. DCs were exposed to photoactivable agent 8-methoxypsolaren (8-MOP) and ultraviolet (UV) A (PUVA) treatment as described in Materials and methods. Immature DCs were activated to mature DCs with addition of 10 ng/ml LPS on day 6. Results are presented as mean of mean fluorescence intensity/or percentage ± s.d. of seven independent experiments.

CD1a CD14 CD40 CD80 CD83 HLA-DR
Immature DCs
 Control 84 ± 10·6% 2·7 ± 1·4% 10·6 ± 2·1% 345·4 ± 57·1
 PUVA treatment 81·2 ± 3% 3·8 ± 2·9% 9·9 ± 1·9% 380·8 ± 45*
Mature DCs
 Control 816·7 ± 52 474·7 ± 38·6 429·3 ± 44 476·5 ± 36·8
 PUVA treatment 807 ± 55 485·8 ± 35·3 421·1 ± 41·4 526·2 ± 17·1
*

Statistical significance (P < 0·01) compared to untreated control DCs. HLA-DR: human leucocyte antigen D-related.